Acne vulgaris and acne rosacea as part of immune reconstitution disease in HIV-1 infected patients starting antiretroviral therapy.
Immune reconstitution disease (IRD) has been widely reported following the commencement of antiretrovirals. We report a case series from a cohort of HIV-1-infected patients of whom four developed acne vulgaris and one developed acne rosacea after the initiation of antiretroviral therapy. Acne vulgaris, as part of IRD, has been reported only once in the literature, whereas acne rosacea has not, to our knowledge, previously been described. This serves as a reminder not to overlook dermatological manifestations of disease in patients with HIV infection after starting antiretrovirals.
Scott
Christopher
C
Chelsea and Westminster Hospital, London, UK. christopher.scott@chelwest.nhs.uk
Staughton
Richard C D
RC
Bunker
Christopher J
CJ
Asboe
David
D
D000152:Acne Vulgaris / Q000150:complications / Q000276:immunology / Q000503:physiopathology; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology* / Q000821:virology; D015497:HIV-1; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced / Q000276:immunology* / Q000503:physiopathology; D008297:Male; D012393:Rosacea / Q000150:complications / Q000276:immunology / Q000503:physiopathology
D019380:Anti-HIV Agents